---
title: "DC 5327 - Muscle, neoplasm of, malignant (excluding soft tissue sarcoma)â100"
diagnostic_code: "5327"
body_system: "Muscle Injuries"
cfr_section: "§ 4.73"
canonical: "https://veteranai.co/va-rating-schedule/muscle-injuries/5327-muscle-neoplasm-of-malignant-excluding-soft-tissue-sarcoma"
source: "https://www.ecfr.gov/current/title-38/section-4.73"
updated: "2026-07-21T20:10:55.413429Z"
---

# DC 5327 - Muscle, neoplasm of, malignant (excluding soft tissue sarcoma)â100

Rated under § 4.73. Body system: Muscle Injuries.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Muscle, neoplasm of, malignant (excluding soft tissue sarcoma)â100 |

## Notes

- Note: A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residual impairment of function.

# Malignant Muscle Neoplasm (Diagnostic Code 5327)

## Understanding This VA Disability Rating

**Diagnostic Code:** 5327
**Regulation:** 38 CFR § 4.73
**Body System:** Muscle Injuries

---

## What This Condition Is

Diagnostic Code 5327 covers a **malignant neoplasm (cancerous tumor) of the muscle**, excluding soft tissue sarcoma. This rating falls under the VA's schedule for evaluating muscle injuries in § 4.73.

---

## Available Rating Level

Under this diagnostic code, there is a single scheduled evaluation:

| Rating | Criteria |
|--------|----------|
| **100%** | Malignant neoplasm of muscle (excluding soft tissue sarcoma) |

---

## What the VA Looks For

The 100 percent rating is assigned for a malignant muscle neoplasm. Beyond the active condition itself, the VA applies specific procedural rules:

- A **100 percent rating continues beyond the cessation** of any surgery, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedures.
- **Six months after treatment is discontinued**, the appropriate disability rating is determined by a **mandatory VA examination**.
- Any change in evaluation based on that examination — or any subsequent examination — is **subject to the provisions of § 3.105(e)**.
- **If there has been no local recurrence or metastasis**, the condition is rated on the **residual impairment of function**.

---

*This information is drawn directly from the VA rating schedule for Diagnostic Code 5327 under 38 CFR § 4.73. It is provided for general educational purposes and does not guarantee any specific rating outcome.*

Source: https://www.ecfr.gov/current/title-38/section-4.73